Occlusion Devices Market Size (2024 - 2029)

The occlusion devices market is anticipated to experience growth over the forecast period, driven by the increasing acceptance of minimally invasive surgeries and the rising prevalence of lifestyle-related and chronic diseases. The market's expansion is supported by technological advancements, although challenges such as high product costs and the need for skilled professionals may impede progress. The impact of the COVID-19 pandemic initially disrupted surgical procedures, affecting the market, but recovery has been observed as restrictions eased and vaccinations increased.

Market Size of Occlusion Devices Industry

Occlusion Devices Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 7.50 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

Occlusion Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Occlusion Devices Market Analysis

The occlusion devices market is expected to register a CAGR of 7.5% during the forecast period.

The COVID-19 pandemic had ramifications on various surgical procedures. Due to the lockdown restrictions, a delay in diagnosis and treatments was observed in patients with various lifestyle-related and chronic diseases as a result of a reduction in hospital visits, which impacted the market studied. For instance, according to the research study published in August 2020, the COVID-19 pandemic negatively impacted interventional radiology services in Canada, especially for elective cases. As per the study, about 49.3% of the respondents reported that there was an overall decline in interventional radiology services in the country. Thus, this data indicates that surgical procedures declined due to the pandemic scenario, which, in turn, affected the occlusion devices market. However, due to the vaccinations and declining cases of COVID-19, the market studied has bounced back to its full potential.

The major factors for the growth of the market include the higher acceptance rate of minimally invasive surgeries (MIS) over traditional surgeries, the increasing prevalence of lifestyle-related and chronic diseases, and technological advancements in the area. For instance, according to the WHO fact sheet of 2021, non-communicable diseases (NCDs), also known as chronic diseases, are responsible for the death of about 41 million people each year, which was about 71% of the total deaths recorded all over the world in 2021. As per the same source, every year, over 15 million people aged between 30-69 die due to NCDs across the world. Therefore, the demand for treatment procedures is increasing owing to the high burden of mortality due to NCDs. Thus, the market studied is expected to grow over the forecast period.

The rising adoption of MIS is expected to drive the overall growth of the market. MIS cause less post-operative pain. Besides, there are minimal cuts or stitches involved, the hospital stay is relatively shorter, and this technology is proving its efficiency in treatment while performing complex surgeries.

However, the high cost of the products and the requirement for skilled professionals are hampering the growth of the market.

Occlusion Devices Industry Segmentation

As per the scope of this report, occlusion devices are used to create occlusion in the vessels in order to stop the blood flow. 

The occlusion devices market is segmented by product (occlusion removal devices (coil retrievers, stent retrievers, and other occlusion removal devices), embolization devices, and support devices), application (peripheral vascular disease, neurology, oncology, urology, and other applications), end user (hospitals, ambulatory surgical centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product
Occlusion Removal Devices
Coil Retrievers
Stent Retrievers
Other Occlusion Removal Devices
Embolization Devices
Support Devices
By Application
Peripheral Vascular Disease
Neurology
Oncology
Urology
Other Applications
By End User
Hospitals
Ambulatory Surgical Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Occlusion Devices Market Size Summary

The occlusion devices market is poised for significant growth, driven by the increasing acceptance of minimally invasive surgeries and advancements in medical technology. The market experienced a temporary setback due to the COVID-19 pandemic, which led to delays in surgical procedures and a decline in interventional radiology services. However, the market has rebounded as vaccination rates increased and COVID-19 cases declined. The rising prevalence of lifestyle-related and chronic diseases, such as non-communicable diseases, is fueling the demand for occlusion devices. These devices are becoming increasingly essential in treating conditions like brain aneurysms, which are influenced by factors such as hypertension and genetic predisposition. The geriatric population's growth is expected to further increase the incidence of such conditions, thereby driving market expansion.

North America is anticipated to lead the occlusion devices market, supported by a robust healthcare infrastructure and a high adoption rate of minimally invasive surgeries. The region's market growth is further bolstered by the approval of new occlusion devices, such as Abbott Laboratories' Amplatzer Piccolo Occluder, which offers innovative treatment options for congenital heart conditions. The rising incidence of cardiovascular diseases and cancer in the United States is also contributing to the market's growth, as these conditions necessitate interventional procedures. The market is characterized by a few major players, including Abbott Laboratories, Boston Scientific Corporation, and Medtronic PLC, who are continuously innovating and expanding their product offerings to meet the growing demand.

Explore More

Occlusion Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Adoption of Minimally Invasive Surgeries

      2. 1.2.2 Increasing Geriatric Population and Rising Burden of Chronic Diseases

      3. 1.2.3 Technological Advancements

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of the Products

      2. 1.3.2 Requirement of Skilled Professionals

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product

      1. 2.1.1 Occlusion Removal Devices

        1. 2.1.1.1 Coil Retrievers

        2. 2.1.1.2 Stent Retrievers

        3. 2.1.1.3 Other Occlusion Removal Devices

      2. 2.1.2 Embolization Devices

      3. 2.1.3 Support Devices

    2. 2.2 By Application

      1. 2.2.1 Peripheral Vascular Disease

      2. 2.2.2 Neurology

      3. 2.2.3 Oncology

      4. 2.2.4 Urology

      5. 2.2.5 Other Applications

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Ambulatory Surgical Centers

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Occlusion Devices Market Size FAQs

The Occlusion Devices Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)

Abbott Laboratories, Boston Scientific Corporation, BTG International Ltd, Edwards Lifesciences Corporation and Medtronic plc are the major companies operating in the Occlusion Devices Market.

Occlusion Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)